CSDB glycosyltransferase search

6 glycosyltransferase activities have been found.
Please note that CSDB GT database covers only a few species: Arabidopsis thaliana, Escherichia coli, Saccharomyces cerevisiae, Acinetobacter baumannii.

Enzyme / Gene	Activity	Object	References
Enzyme name: PBP1A UniProt ID: O66874 CAZy family: GT51 Gene name: mrcA Gene GenBank ID: 1193936	Synthesized dimer: bDGlcpN(1-4)bMurp Donor (ID 35243): Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol Acceptor (ID 35243): Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol Status: evidence in vitro Confirmation methods: in vitro (purified protein), mutation (in recombinant protein) ID: 3000 Notes: The PGT domain of PBP1A was used. N of murein units varied from 2 to >20.	Organism (ID 17331): Aquifex aeolicus Full structure (ID 35244):	Barrett et al. 2007 DOI: 10.1074/jbc.M705440200
Synthesized dimer: bDGlcpN(1-4)bMurp Donor (ID 35245): Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]bXMurp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol Acceptor (ID 35245): Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]bXMurp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol Status: evidence in vitro Confirmation methods: in vitro (purified protein) ID: 3001 Notes: The PGT domain of PBP1A was used. N of murein units was 4, 6, and 8; short products accumulated before longer products appeared.	Organism (ID 17331): Aquifex aeolicus Full structure (ID 35246):
Synthesized dimer: bDGlcpN(1-4)bMurp Donor (ID 35247): Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27,31,35,39,43-undecamethyl-tetratetraconta-2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E,42-undecaen-1-ol Acceptor (ID 35248): b?Galp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27,31,35,39,43-undecamethyl-tetratetraconta-2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E,42-undecaen-1-ol Status: evidence in vitro Confirmation methods: in vitro (purified protein) ID: 3002 Notes: N of murein units varied from 3 to higher. The study was aimed at revealing the direction of chain elongation.	Organism (ID 17331): Aquifex aeolicus Full structure (ID 35249):	Perlstein et al. 2007 DOI: 10.1021/ja075965y
Enzyme name: PBP2 UniProt ID: Q9R744 CAZy family: GT51	Synthesized dimer: bDGlcpN(1-4)bMurp Donor (ID 35247): Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27,31,35,39,43-undecamethyl-tetratetraconta-2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E,42-undecaen-1-ol Acceptor (ID 35248): b?Galp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27,31,35,39,43-undecamethyl-tetratetraconta-2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E,42-undecaen-1-ol Status: evidence in vitro Confirmation methods: in vitro (purified protein) ID: 3003 Notes: N of murein units varied from 3 to higher. The study was aimed at revealing the direction of chain elongation.	Organism (ID 976): Staphylococcus aureus Full structure (ID 35249):
Synthesized dimer: bDGlcpN(1-4)bMurp Donor (ID 35243): Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol Acceptor (ID 35243): Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol Status: evidence in vitro Confirmation methods: in vitro (purified protein) ID: 3004 Notes: Lipid II is utilized as donor/substrate. Lipid II derivatives may vary. The limiting length was about 15 units (Lipid 30).	Organism (ID 976): Staphylococcus aureus Full structure (ID 35244):	Wang et al. 2008 DOI: 10.1021/ja806016y Barrett et al. 2005 DOI: 10.1128/JB.187.6.2215-2217.2005
Enzyme name: PBP2A UniProt ID: X5NX71	Synthesized dimer: bDGlcpN(1-4)bMurp Donor (ID 35243): Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol Acceptor (ID 35243): Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol Status: evidence in vitro Confirmation methods: in vitro (purified truncated protein) ID: 3005	Organism (ID 451): Enterococcus faecalis Full structure (ID 35244):	Wang et al. 2008 DOI: 10.1021/ja806016y

#GTR ID	Enzyme name	Enzyme group	Enzyme Genbank ID	Derived ID mark	Enzyme Uniprot ID	Derived ID mark	CAZY family	Gene name	Gene Genbank ID	Derived ID mark	Gene cluster	Full structure CSDB structure ID	Side product CSDB structure ID	Full structure	Full structure is fragment (0|1)	Synthesized bond	Synthesized bond location (from root ~ subst position)	Donor structure ID	Substrate structure	Confirmation status	Methods used	Notes	Molecule role	Molecule is a model of role (0|1)	Molecule is a precursor of role (0|1)	Main CSDB record ID	Additional CSDB record IDs	CSDB organism IDs	Organism names	Organs and tissues	References (;-separated)
3000	PBP1A				O66874		GT51	mrcA	1193936			35244		Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]bXMurp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol	0	bDGlcpN(1-4)bXMurp	?~4	Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol	Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol	in vitro	in vitro (purified protein), mutation (in recombinant protein)	The PGT domain of PBP1A was used. N of murein units varied from 2 to >20.		0	0			17331	Aquifex aeolicus 		Barrett et al. 2007 (doi: 10.1074/jbc.M705440200)	
3001	PBP1A				O66874		GT51	mrcA	1193936			35246		Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]bXMurp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]bXMurp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]bXMurp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol	0	bDGlcpN(1-4)bXMurp	?~4	Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]bXMurp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol	Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]bXMurp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol	in vitro	in vitro (purified protein)	The PGT domain of PBP1A was used. N of murein units was 4, 6, and 8; short products accumulated before longer products appeared.		0	0			17331	Aquifex aeolicus 		Barrett et al. 2007 (doi: 10.1074/jbc.M705440200)	
3002	PBP1A				O66874		GT51	mrcA	1193936			35249		b?Galp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]bXMurp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27,31,35,39,43-undecamethyl-tetratetraconta-2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E,42-undecaen-1-ol	0	bDGlcpN(1-4)bXMurp	?~4	Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27,31,35,39,43-undecamethyl-tetratetraconta-2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E,42-undecaen-1-ol	b?Galp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27,31,35,39,43-undecamethyl-tetratetraconta-2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E,42-undecaen-1-ol	in vitro	in vitro (purified protein)	N of murein units varied from 3 to higher. The study was aimed at revealing the direction of chain elongation.		0	0			17331	Aquifex aeolicus 		Perlstein et al. 2007 (doi: 10.1021/ja075965y)	
3003	PBP2				Q9R744		GT51					35249		b?Galp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]bXMurp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27,31,35,39,43-undecamethyl-tetratetraconta-2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E,42-undecaen-1-ol	0	bDGlcpN(1-4)bXMurp	?~4	Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27,31,35,39,43-undecamethyl-tetratetraconta-2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E,42-undecaen-1-ol	b?Galp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27,31,35,39,43-undecamethyl-tetratetraconta-2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E,42-undecaen-1-ol	in vitro	in vitro (purified protein)	N of murein units varied from 3 to higher. The study was aimed at revealing the direction of chain elongation.		0	0			976	Staphylococcus aureus 		Perlstein et al. 2007 (doi: 10.1021/ja075965y)	
3004	PBP2				Q9R744		GT51					35244		Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]bXMurp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol	0	bDGlcpN(1-4)bXMurp	?~4	Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol	Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol	in vitro	in vitro (purified protein)	Lipid II is utilized as donor/substrate. Lipid II derivatives may vary. The limiting length was about 15 units (Lipid 30).		0	0			976	Staphylococcus aureus 		Wang et al. 2008 (doi: 10.1021/ja806016y); Barrett et al. 2005 (doi: 10.1128/JB.187.6.2215-2217.2005)	
3005	PBP2A				X5NX71							35244		Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]bXMurp(1-4)[Ac(1-2)]bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol	0	bDGlcpN(1-4)bXMurp	?~4	Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol	Ac(1-2)bDGlcpN(1-4)[xDAla?(2-1)xDAla?(2-1)xLLys(2-5)xDGlu(2-1)xLAla?(2-8)]aXMurp(1-P-P-1)Subst // Subst = 3,7,11,15,19,23,27-heptamethyl-octacosa-2Z,6Z,10Z,14Z,18E,22E,26-heptaen-1-ol	in vitro	in vitro (purified truncated protein)			0	0			451	Enterococcus faecalis 		Wang et al. 2008 (doi: 10.1021/ja806016y)